Few of the many nonpharmacologic efforts to mitigate the spread of COVID-19 in nursing homes during the pandemic were ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

Genomic testing in UK dairy herds reaches an all-time high in 2024, with 112,507 females assessed—marking a 19 rise from the previous year.